Molecular Testing for Thyroid Nodules: Past, Present & Future with Dr. Raghunathan

We are honored to have Dr. Rajam Raghunathan present "Molecular Testing for Indeterminate Thyroid Nodules Past, Present & Future." Dr. Kepal Patel joins as the featured expert discussant. 0:00 Webinar 2:15 Dr. Raghunathan presents 5:00 Molecular Testing Utility Dr. Raghunathan explains molecular diagnostics as crucial for managing indeterminate cytology cases, such as Bethesda III and IV. These diagnostics guide treatment for 30% of U.S. FNA biopsies, reducing unnecessary surgeries and related costs by managing over 90% of benign cases nonoperatively. 8:00 Types & Utility of Molecular Testing Dr. Raghunathan discusses the selection and clinical impact of various molecular tests, stressing their role in pre-operative risk assessment despite histology remaining the definitive standard. 25:22 Dr. Patel presents 32:00 Appropriateness of Molecular Testing Dr. Patel considers molecular testing valuable primarily as a pre-operative adjunct to refine cancer risk assessment, particularly when thyroidectomy decisions are uncertain due to ambiguous clinical, imaging, and cytologic features. 42:39 Discussion with Q&A ** Check out our other programs! ** The THANC Guide https://thancguide.org/ TIRO: Thyroid Int'l Recommendations Online https://tiro.expert/ ** Follow us on Twitter! ** @thancfoundation - https://shorturl.at/puwS0 THANC on FB - https://shorturl.at/svNY4